GSK launched a 2 billion pounds ($2.5 billion) share buyback on Wednesday and lifted its long-term sales target to nearly $50 ...

Two weeks into the Trump administration, external communication from federal health agencies, including the Centers for ...

GSK, a UK-based biopharma, reported strong 2024 results, with a promising shift toward specialty medicines. Read why I ...

The United States' recent announcement to withdraw from the World Health Organization (WHO) has raised concerns across the global health community, particularly regarding the potential disruption of ...

President Donald Trump's decision to freeze foreign assistance has sent aid staff in Africa into "panic mode", with even HIV ...

Staffers at the U.S. Agency for International Development were stunned and angered on Monday after President Donald Trump and cost cutter Elon Musk shut down the $40 billion agency.

Plus: A new non-opioid painkiller, the wave of lawsuits against Trump EOs, a key vote for RFK Jr., a big radiopharma deal and ...

Q4 2024Management ViewCEO Dame Emma Walmsley highlighted that GSK achieved 8% sales growth in 2024, reaching over ...

President Trump’s pause on aid, and the gutting of the primary aid agency, could jeopardize the health of more than 20 ...

Africa’s leading public health official will write to the U.S. Secretary of State on Thursday to highlight how the U.S. aid freeze is threatening the lives of people across the continent and efforts ...

Latonia Wilkins knows she needs to be on PrEP due to her non-monogamous lifestyle. But the 52-year-old Atlanta mother has faced repeated challenges getting the lifesaving drug that can prevent new HIV ...